Author

C.-M. Cheng

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1

Frequent Co-Authors

B.-H. Chen· 1 shared C.-C. Lee· 1 shared C.-C. Lin· 1 shared C.-F. Hsu· 1 shared C.-H. Hsieh· 1 shared C.-P. Sun· 1 shared C.-W. Chiu· 1 shared C.-W. Wu· 1 shared

Activity by Year

2018-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

B.-H. Chen

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Omicron-specific mRNA vaccine induced potent neutralizing antibody against Omicron but not other SARS-CoV-2 variants

I.-J. Lee, C.-P. Sun, P.-Y. Wu, Y.-H. Lan, I.-H. Wang, W.-C. Liu, S.-C. Tseng, S.-I. Tsung, Y.-C. Chou, M. Kumari, Y.-W. Chang, H.-F. Chen, Y.-S. Lin, T. -Y. Chen, C.-W. Chiu, , M.-H. Tao

This study evaluates Omicron-specific mRNA vaccines and finds they induce strong neutralizing antibodies against Omicron but not other variants, while bivalent vaccines show broader neutralizing activity.

bioRxiv · Jan 31, 2022Microbiology

Targeting BMI1 and MCL1 for Lung Adenocarcinoma Treatment

E.-H. Lin, C.-F. Hsu, Y.-H. Jan, T.-H. Lin, H.-Y. Chang, C.-M. Cheng, H.-J. Hsu, W.-W. Chen, B.-H. Chen, H.-F. Tsai, J.-J. Li, C.-Y. Huang, S.-H. Chuang, J.-M. Chang, M. Hsiao, C.-W. Wu

This study identifies BMI1 and MCL1 as key drivers of lung adenocarcinoma progression and demonstrates that targeting these proteins with a novel small-molecule inhibitor suppresses tumor growth in preclinical models.

bioRxiv · Oct 22, 2018 · PreprintCancer Biology